CAM
Chou Associates Management Portfolio holdings
AUM
$183M
This Quarter Return
-0.84%
1 Year Return
+14.81%
3 Year Return
+92%
5 Year Return
+295.47%
10 Year Return
+349.45%
AUM
$301M
AUM Growth
+$301M
(-3.6%)
Cap. Flow
-$9.18M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
76.26%
Holding
30
New
2
Increased
2
Reduced
3
Closed
2
Top Buys
| 1 |
ENDP
Endo International plc
ENDP
|
$10.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$6.9M |
| 3 |
Bausch Health
BHC
|
$4.33M |
| 4 |
SandRidge Energy
SD
|
$2M |
Top Sells
| 1 |
JPM.WS
JPMorgan Chase
JPM.WS
|
$23.2M |
| 2 |
Nokia
NOK
|
$5.42M |
| 3 |
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
|
$3.39M |
| 4 |
AstraZeneca
AZN
|
$711K |
| 5 |
GSK
GSK
|
$347K |
Sector Composition
| 1 | Financials | 29.32% |
| 2 | Healthcare | 20.58% |
| 3 | Consumer Discretionary | 10.15% |
| 4 | Technology | 6.3% |
| 5 | Industrials | 2.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AstraZeneca
AZN
$255B
| – | – |
-13,000
| Closed | -$711K |
|
|
27
GSK
GSK
$79.3B
| – | – |
-14,400
| Closed | -$347K |
|